{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:31:14Z","timestamp":1787020274535,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Clinical Features Reserach of Capital","award":["Z151100004015173"],"award-info":[{"award-number":["Z151100004015173"]}]},{"name":"Collaborative Research Foundation of Peking University Health Science Center and National Taiwan University, the College of Medicine","award":["BMU20120318"],"award-info":[{"award-number":["BMU20120318"]}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing","doi-asserted-by":"crossref","award":["7152146"],"award-info":[{"award-number":["7152146"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010270","name":"the Capital Health Research and Development of Special","doi-asserted-by":"crossref","award":["2016-1-4077"],"award-info":[{"award-number":["2016-1-4077"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fund for Fostering Young Scholars of Peking University Health Science Center","award":["BMU2017PY009"],"award-info":[{"award-number":["BMU2017PY009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12894-018-0334-7","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T23:17:47Z","timestamp":1522797467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6746-6559","authenticated-orcid":false,"given":"Dong","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengyan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmish","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenpeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"issue":"2","key":"334_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000343514","volume":"6","author":"M Perez-Utrilla Perez","year":"2012","unstructured":"Perez-Utrilla Perez M, Aguilera Bazan A, Alonso Dorrego JM, Viton Herrero R, Cisneros Ledo J, de la Pena Barthel J. Simultaneous cystectomy and Nephroureterectomy due to synchronous upper urinary tract tumors and invasive bladder Cancer: open and laparoscopic approaches. Currt Urol. 2012;6(2):76\u201381.","journal-title":"Currt Urol"},{"issue":"1","key":"334_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10\u201329.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"334_CR3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0094-0143(21)00144-0","volume":"7","author":"KB Cummings","year":"1980","unstructured":"Cummings KB. Nephroureterectomy: rationale in the management of transitional cell carcinoma of the upper urinary tract. Urol Clin North Am. 1980;7(3):569\u201378.","journal-title":"Urol Clin North Am"},{"key":"334_CR4","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1038\/srep06361","volume":"4","author":"Y Wu","year":"2014","unstructured":"Wu Y, Dong Q, Liu L, Han P, Wei Q. The impact of tumor location and multifocality on prognosis for patients with upper tract urothelial carcinoma: a meta-analysis. Sci Rep. 2014;4:6361.","journal-title":"Sci Rep"},{"issue":"6","key":"334_CR5","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.eururo.2009.07.002","volume":"57","author":"JD Raman","year":"2010","unstructured":"Raman JD, Ng CK, Scherr DS, Margulis V, Lotan Y, Bensalah K, Patard JJ, Kikuchi E, Montorsi F, Zigeuner R, Weizer A, Bolenz C, Koppie TM, Isbarn H, Jeldres C, Kabbani W, Remzi M, Waldert M, Wood CG, Roscigno M, Oya M, Langner C, Wolf JS, Strobel P, Fernandez M, Karakiewcz P, Shariat SF. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol. 2010;57(6):1072\u20139.","journal-title":"Eur Urol"},{"issue":"5","key":"334_CR6","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.juro.2009.07.035","volume":"182","author":"H Isbarn","year":"2009","unstructured":"Isbarn H, Jeldres C, Shariat SF, Liberman D, Sun M, Lughezzani G, Widmer H, Arjane P, Pharand D, Fisch M, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. J Urol. 2009;182(5):2177\u201381.","journal-title":"J Urol"},{"issue":"3","key":"334_CR7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1245\/s10434-013-3349-z","volume":"21","author":"N Tanaka","year":"2014","unstructured":"Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Kobayashi H, Ide H, Miyazaki Y, Obata J, Hoshino K, Shirotake S, Akita H, Kosaka T, Miyajima A, Momma T, Nakagawa K, Hasegawa S, Nakajima Y, Jinzaki M, Oya M. Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor location. Ann Surg Oncol. 2014;21(3):1038\u201345.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"334_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00345-015-1584-6","volume":"34","author":"LM Krabbe","year":"2016","unstructured":"Krabbe LM, Bagrodia A, Westerman ME, Gayed BA, Haddad AQ, Sagalowsky AI, Shariat SF, Kapur P, Lotan Y, Margulis V. Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different? World J Urol. 2016;34(1):105\u201312.","journal-title":"World J Urol"},{"issue":"1","key":"334_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00345-012-0946-6","volume":"31","author":"DR Yates","year":"2013","unstructured":"Yates DR, Catto JW. Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours. World J Urol. 2013;31(1):21\u20139.","journal-title":"World J Urol"},{"issue":"54","key":"334_CR10","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1038\/sj.onc.1206964","volume":"22","author":"JW Catto","year":"2003","unstructured":"Catto JW, Azzouzi AR, Amira N, Rehman I, Feeley KM, Cross SS, Fromont G, Sibony M, Hamdy FC, Cussenot O, Meuth M. Distinct patterns of microsatellite instability are seen in tumours of the urinary tract. Oncogene. 2003;22(54):8699\u2013706.","journal-title":"Oncogene"},{"issue":"13","key":"334_CR11","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1200\/JCO.2005.03.163","volume":"23","author":"JW Catto","year":"2005","unstructured":"Catto JW, Azzouzi AR, Rehman I, Feeley KM, Cross SS, Amira N, Fromont G, Sibony M, Cussenot O, Meuth M, Hamdy FC. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol. 2005;23(13):2903\u201310.","journal-title":"J Clin Oncol"},{"issue":"5","key":"334_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2217\/epi.15.34","volume":"7","author":"G Xiong","year":"2015","unstructured":"Xiong G, Liu J, Tang Q, Fan Y, Fang D, Yang K, Xie F, Zhang M, Zhang L, Liu L, Zhang C, Yao L, Yang L, Ci W, Zhao W, Gong Y, He Q, Gong K, He Z, Wang G, Li X, Guo Y, Zhou L. Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma. Epigenomics. 2015;7(5):733\u201344.","journal-title":"Epigenomics"},{"issue":"10","key":"334_CR13","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1681\/ASN.2006040368","volume":"17","author":"YC Ma","year":"2006","unstructured":"Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937\u201344.","journal-title":"J Am Soc Nephrol"},{"issue":"18","key":"334_CR14","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"93","author":"JG Herman","year":"1996","unstructured":"Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996;93(18):9821\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"334_CR15","doi-asserted-by":"publisher","first-page":"7296","DOI":"10.1158\/1078-0432.CCR-07-0861","volume":"13","author":"J Yu","year":"2007","unstructured":"Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, Gao B, Wang W, Gu L, Meng J, Wang J, Feng X, Li Y, Yao X, Zhu J. A novel set of DNA methylation markers in urine sediments for sensitive\/specific detection of bladder cancer. Clin Cancer Res. 2007;13(24):7296\u2013304.","journal-title":"Clin Cancer Res"},{"issue":"24","key":"334_CR16","first-page":"8659","volume":"61","author":"R Maruyama","year":"2001","unstructured":"Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zochbauer-Muller S, Farinas AJ, Vakar-Lopez F, Minna JD, Sagalowsky A, Czerniak B, Gazdar AF. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res. 2001;61(24):8659\u201363.","journal-title":"Cancer Res"},{"issue":"23","key":"334_CR17","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.1158\/1078-0432.CCR-10-1312","volume":"16","author":"VL Costa","year":"2010","unstructured":"Costa VL, Henrique R, Danielsen SA, Duarte-Pereira S, Eknaes M, Skotheim RI, Rodrigues A, Magalhaes JS, Oliveira J, Lothe RA, Teixeira MR, Jeronimo C, Lind GE. Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples. Clin Cancer Res. 2010;16(23):5842\u201351.","journal-title":"Clin Cancer Res"},{"issue":"18","key":"334_CR18","first-page":"6688","volume":"61","author":"MG Lee","year":"2001","unstructured":"Lee MG, Kim HY, Byun DS, Lee SJ, Lee CH, Kim JI, Chang SG, Chi SG. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res. 2001;61(18):6688\u201392.","journal-title":"Cancer Res"},{"key":"334_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1756-9966-32-94","volume":"32","author":"V Casadio","year":"2013","unstructured":"Casadio V, Molinari C, Calistri D, Tebaldi M, Gunelli R, Serra L, Falcini F, Zingaretti C, Silvestrini R, Amadori D, Zoli W. DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach. J Exp Clin Cancer Res. 2013;32:94.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"334_CR20","first-page":"2847","volume":"61","author":"GH Kang","year":"2001","unstructured":"Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 2001;61(7):2847\u201351.","journal-title":"Cancer Res"},{"issue":"6","key":"334_CR21","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","volume":"67","author":"T Seisen","year":"2015","unstructured":"Seisen T, Granger B, Colin P, Leon P, Utard G, Renard-Penna R, Comperat E, Mozer P, Cussenot O, Shariat SF, Roupret M. A systematic review and meta-analysis of Clinicopathologic factors linked to Intravesical recurrence after radical Nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol. 2015;67(6):1122\u201333.","journal-title":"Eur Urol"},{"issue":"11","key":"334_CR22","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jfma.2013.11.004","volume":"113","author":"D Fang","year":"2014","unstructured":"Fang D, Xiong GY, Li XS, Chen XP, Zhang L, Yao L, He ZS, Zhou LQ. Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a large Chinese center experience. J Formos Med Assoc. 2014;113(11):820\u20137.","journal-title":"J Formos Med Assoc"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-018-0334-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12894-018-0334-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-018-0334-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T19:45:00Z","timestamp":1660765500000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-018-0334-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["334"],"URL":"https:\/\/doi.org\/10.1186\/s12894-018-0334-7","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"12 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received the ethics approval by the Ethic Committee of Peking University First Hospital (No. 2016\u20131253).All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.All patients agreed and signed the informed consent to participate into the study, and they agreed that their information (including clinical information, surgical related data, pathological data and surveillance) would be collected for scientific study and by published in professional medical journals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"22"}}